Clear Street analyst Tim Moore upgrades Tetra Technologies (NYSE:TTI) from Hold to Buy and announ

SPRING, Texas, Sept. 30, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE: TTI) will release Thir

Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and lowers the

Valaris (NYSE: VAL - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both

MIND Technology (NASDAQ: MIND - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report

San Diego, California--(Newsfile Corp. - September 21, 2026) - Thiogenesis Therapeutics, Corp. (TSXV

Tetra Technologies is an interesting investment opportunity, given the sizable share price pullback

Gainers TMD Energy (AMEX:TMDE) stock increased by 3.6% to $0.72 during Thursday's after-market

San Diego, California--(Newsfile Corp. - September 3, 2026) - Thiogenesis Therapeutics, Corp. (TSXV:

SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NY

Technip Energies (OTCMKTS:THNPY - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Repo

Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Coliti

Tetra Technologies NYSE: TTI reported second-quarter revenue of $185.7 million, up 19% sequentially

Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed

TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript

Tetra Technologies (TTI) came out with quarterly earnings of $0.08 per share, in line with the Zacks

Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed

SPRING, Texas, Aug. 3, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYS

STAT3 acts as a convergent node downstream of multiple signaling pathways implicated in ulcerative c

Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a like

SPRING, Texas, July 13, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release Second

San Diego, California--(Newsfile Corp. - July 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI

Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prod

Northland Capital Markets analyst Bobby Brooks maintains Tetra Technologies (NYSE:TTI) with a Out

Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the p

TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the c

Phase 1 of the Evergreen Project, which included site preparation, power infrastructure, and install

"The Board's approval of the final investment decision for our Arkansas bromine facility mar

Tetra Technologies (NYSE:TTI) reported quarterly earnings of $0.02 per share which met the analyst c

Clear Street analyst Tim Moore downgrades Tetra Technologies (NYSE:TTI) from Buy to Hold and rais

Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and raises the

Northland Capital Markets analyst Greg Gibas maintains Tetra Technologies (NYSE:TTI) with a Outpe

CJS Securities analyst Jonathan Tanwanteng initiates coverage on Tetra Technologies (NYSE:TTI) wi

Tetra Technologies (NYSE:TTI) raises FY2025 sales outlook from $610.000 million-$630.000 million to

Tetra Technologies (NYSE:TTI) reported quarterly earnings of $0.04 per share which beat the analyst

Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and raises the

Tetra Technologies (NYSE: TTI) has been analyzed by 4 analysts in the last three months, revealing a

Northland Capital Markets analyst Greg Gibas maintains Tetra Technologies (NYSE: TTI) with a Outp

Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and raises the